| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN.
Address correspondence and reprint requests to Dr. Duygu Selcen, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail: selcen.duygu{at}mayo.edu
Background and Objective: The term myofibrillar myopathy (MFM) is a noncommittal term for a pathologic pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins. Ultrastructural studies implicate the Z-disk as the site of the initial pathologic change, and mutations in two Z-disk-related proteins, desmin and 
B-crystallin, have been identified in a minority of patients with MFM. The authors’ objective was to determine whether mutations in myotilin, a key Z-disk component and the disease protein in limb-girdle muscular dystrophy (LGMD) 1A, are another cause of MFM.
Methods: The authors used histochemical, immunocytochemical, ultrastructural, and mutation analysis.
Results: The authors detected four missense mutations in 6 of 57 patients with MFM in the serine-rich exon 2 of MYOT, where the two previously identified LGMD1A mutations are located. Three mutations were novel, and one had been previously identified in LGMD1A. Each patient had evidence for neuropathy, and at least three kinships had associated cardiomyopathy. Distal weakness greater than proximal weakness was present in three patients. Except for minor differences, the morphologic features were similar to those in other patients with MFM.
Conclusions: 1) Mutations in myotilin cause MFM; 2) exon 2 of MYOT is a hotspot for mutations; 3) peripheral neuropathy, cardiomyopathy, and distal weakness greater than proximal weakness are part of the spectrum of myotilinopathy; 4) not all cases of myotilinopathy have a limb-girdle phenotype; and 5) the molecular basis of the majority of MFM cases remains to be discovered.
Received December 22, 2003. Accepted in final form February 9, 2004.
See also page 1248
This article has been cited by other articles:
|
|
 |
|
  M. Zheng, H. Cheng, X. Li, J. Zhang, L. Cui, K. Ouyang, L. Han, T. Zhao, Y. Gu, N. D. Dalton, et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death Hum. Mol. Genet., February 15, 2009; 18(4): 701 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. von Nandelstadh, M. Ismail, C. Gardin, H. Suila, I. Zara, A. Belgrano, G. Valle, O. Carpen, and G. Faulkner A Class III PDZ Binding Motif in the Myotilin and FATZ Families Binds Enigma Family Proteins: a Common Link for Z-Disc Myopathies Mol. Cell. Biol., February 1, 2009; 29(3): 822 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Walker, T.K. Rajendra, L. Saieva, J. L. Fuentes, L. Pellizzoni, and A. G. Matera SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain Hum. Mol. Genet., November 1, 2008; 17(21): 3399 - 3410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fischer, R. A. Kley, K. Strach, C. Meyer, T. Sommer, K. Eger, A. Rolfs, W. Meyer, A. Pou, J. Pradas, et al. Distinct muscle imaging patterns in myofibrillar myopathies Neurology, September 2, 2008; 71(10): 758 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Berciano, E Gallardo, R Dominguez-Perles, E Gallardo, A Garcia, R Garcia-Barredo, O Combarros, J Infante, and I Illa Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 205 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kley, Y. Hellenbroich, P. F. M. van der Ven, D. O. Furst, A. Huebner, V. Bruchertseifer, S. A. Peters, C. M. Heyer, J. Kirschner, R. Schroder, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients Brain, December 1, 2007; 130(12): 3250 - 3264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barrachina, J. Moreno, S. Juves, D. Moreno, M. Olive, and I. Ferrer Target Genes of Neuron-Restrictive Silencer Factor Are Abnormally Up-Regulated in Human Myotilinopathy Am. J. Pathol., October 1, 2007; 171(4): 1312 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lowe, R. A. Kley, P. F.M. van der Ven, M. Himmel, A. Huebner, M. Vorgerd, and D. O. Furst The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy Hum. Mol. Genet., June 1, 2007; 16(11): 1351 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Walter, P. Reilich, A. Huebner, D. Fischer, R. Schroder, M. Vorgerd, W. Kress, C. Born, B. G. Schoser, K. H. Krause, et al. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P Brain, June 1, 2007; 130(6): 1485 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Moza, L. Mologni, R. Trokovic, G. Faulkner, J. Partanen, and O. Carpen Targeted Deletion of the Muscular Dystrophy Gene myotilin Does Not Perturb Muscle Structure or Function in Mice Mol. Cell. Biol., January 1, 2007; 27(1): 244 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Garvey, S. E. Miller, D. R. Claflin, J. A. Faulkner, and M. A. Hauser Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM Hum. Mol. Genet., August 1, 2006; 15(15): 2348 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ono, R. Yu, K. Mohri, and S. Ono Caenorhabditis elegans Kettin, a Large Immunoglobulin-like Repeat Protein, Binds to Filamentous Actin and Provides Mechanical Stability to the Contractile Apparatuses in Body Wall Muscle Mol. Biol. Cell, June 1, 2006; 17(6): 2722 - 2734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Foroud, N. Pankratz, A. P. Batchman, M. W. Pauciulo, R. Vidal, L. Miravalle, H. H. Goebel, L. J. Cushman, B. Azzarelli, H. Horak, et al. A mutation in myotilin causes spheroid body myopathy Neurology, December 27, 2005; 65(12): 1936 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Olive, L. G. Goldfarb, A. Shatunov, D. Fischer, and I. Ferrer Myotilinopathy: refining the clinical and myopathological phenotype Brain, October 1, 2005; 128(10): 2315 - 2326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gontier, A. Taivainen, L. Fontao, A. Sonnenberg, A. van der Flier, O. Carpen, G. Faulkner, and L. Borradori The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins J. Cell Sci., August 15, 2005; 118(16): 3739 - 3749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, C. Blagden, J. Fan, S. J. Nowak, I. Taniuchi, D. R. Littman, and S. J. Burden Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle Genes & Dev., July 15, 2005; 19(14): 1715 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bar, D. Fischer, B. Goudeau, R. A. Kley, C. S. Clemen, P. Vicart, H. Herrmann, M. Vorgerd, and R. Schroder Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro Hum. Mol. Genet., May 15, 2005; 14(10): 1251 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Goebel Congenital Myopathies in the New Millennium J Child Neurol, February 1, 2005; 20(2): 94 - 101. [Abstract] [PDF]
|
|
|
|
 |
|
 The Clinical and Genetic Spectrum of Myofibrillar (Desmin) Myopathy Journal Watch Neurology, June 11, 2004; 2004(611): 7 - 7. [Full Text]
|
|
|
|
|
|
G. Karpati and M. Sinnreich A clever road from myopathology to genes: The myotilin story Neurology, April 27, 2004; 62(8): 1248 - 1249. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
